We are live on ! Find out more
ICUI icon

ICU Medical

226 hedge funds and large institutions have $2.95B invested in ICU Medical in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 69 increasing their positions, 85 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

9% more capital invested

Capital invested by funds: $2.7B → $2.95B (+$250M)

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

0.17% more ownership

Funds ownership: 79.39%79.56% (+0.17%)

0% more funds holding

Funds holding: 226226 (0)

19% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 85

86% less call options, than puts

Call options by funds: $632K | Put options by funds: $4.37M

Holders
226
Holders Change
Holders Change %
0%
% of All Funds
5.63%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
29
Increased
69
Reduced
85
Closed
27
Calls
$632K
Puts
$4.37M
Net Calls
-$3.74M
Net Calls Change
-$5.79M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$338M +$6.33M +36,293 +2%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$313M +$43.9M +251,793 +18%
Vanguard Group
3
Vanguard Group
Pennsylvania
$254M +$11.3M +65,019 +5%
Wells Fargo
4
Wells Fargo
California
$104M +$880K +5,044 +0.9%
GKIM
5
GW&K Investment Management
Massachusetts
$92M -$76.4K -438 -0.1%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$86.8M -$29.2M -167,165 -26%
Renaissance Technologies
7
Renaissance Technologies
New York
$82.3M -$25.3M -145,300 -25%
JP Morgan Chase
8
JP Morgan Chase
New York
$80.1M +$2.54M +14,537 +3%
SAM
9
Silvercrest Asset Management
New York
$79.7M -$9.78M -56,103 -12%
State Street
10
State Street
Massachusetts
$72.2M +$17.1K +98 +0%
Goldman Sachs
11
Goldman Sachs
New York
$71.2M -$967K -5,548 -1%
CIP
12
Champlain Investment Partners
Vermont
$69.7M -$22.3M -127,921 -25%
Millennium Management
13
Millennium Management
New York
$66.5M +$32.1M +184,263 +106%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$65M -$8.04M -46,111 -12%
Invesco
15
Invesco
Georgia
$60.7M +$655K +3,755 +1%
GT
16
Glenmede Trust
Pennsylvania
$48.8M -$15.7M -89,814 -26%
Bank of America
17
Bank of America
North Carolina
$45.7M +$12.9M +73,922 +43%
Fiera Capital (Canada)
18
Fiera Capital (Canada)
Quebec, Canada
$44.3M +$4.19M +24,031 +11%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$44M -$1.11M -6,344 -3%
Northern Trust
20
Northern Trust
Illinois
$38.5M -$746K -4,280 -2%
RG
21
Redmile Group
California
$37.5M +$12.1M +69,245 +52%
EAM
22
Eagle Asset Management
Florida
$36.6M +$755K +4,330 +2%
ECP
23
Elk Creek Partners
Colorado
$35M +$1.51M +8,656 +5%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$34M -$424K -2,433 -1%
Norges Bank
25
Norges Bank
Norway
$29.9M +$7.63M +43,781 +37%

ICUI Hedge Fund Activity: Q3 2017 in Review

226 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2017, worth a combined $2.95B — up 9.2% from $2.7B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ICUI positions and 27 closed out — a net gain of 2 holders — while 69 added to existing stakes and 85 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $43.9M. The largest seller was Principal Financial Group, cutting an estimated $31.4M.

  • 226 institutional investors held ICU Medical (ICUI) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $2.95B of ICU Medical stock for Q3 2017, up 9.2% quarter-over-quarter.
  • 29 funds opened new ICU Medical positions in Q3 2017 and 27 closed out, a net change of +2 holders.
  • The largest ICU Medical buyer in Q3 2017 was Janus Henderson Group, an estimated $43.9M added.
  • The largest ICU Medical seller in Q3 2017 was Principal Financial Group, an estimated $31.4M sold.

Based on aggregated 13F filings for Q3 2017.